Mr. David Ebersman is a Co-Founder and serves as Chief Executive Officer and Board Member at Lyra Health. He is a Board member at Castlight Health. He served as a Board Member at Trust Science. He served as Chief Financial Officer of Facebook. Prior to joining Facebook, he held a number of positions at Genentech, a leading public biotechnology company, until its acquisition by Hoffmann-La Roche in March 2009. He served as Executive Vice President in January 2006 and Chief financial officer in March 2005 at Genentech. Previously, he served as Senior Vice President, Finance from January 2005 through March 2005 and Senior Vice President, Product Operations from May 2001 through January 2005. Prior to joining Genentech, He held the position of research analyst at Oppenheimer & Company. Mr. Ebersman was selected as a Fellow in the Henry Crown Fellowship Program. Mr. Ebersman received a B.A. in economics and international relations from Brown University. He serves as Board Member at Castlight Health. He serves as Chairman of the Board and Chairman of Nominating and Corporate Governance Committee at SVMK.